Additional file 6: of The neoepitope landscape of breast cancer: implications for immunotherapy

Melissa Wilson (Contributor)
Meixuan Chen (Contributor)
Pooja Narang (Contributor)
Amit A. Sharma (Contributor)
Karen Anderson (Contributor)

Dataset

Description

Figure S4. Length of potential binding neoepitopes in breast cancer. The number of potential binding neoepitopes (IEDB â ¤500) are plotted against peptide sizes (8, 9, 10, 11 mers). 4% of the predicted neoepitopes are 8-mers, 57% of the predicted neoepitopes are 9-mer, 33% of the predicted neoepitopes are 10-mers and 6% are 11mers (PDF 101 kb)

Date made available	Mar 4 2019
Publisher	figshare Academic Research System

DOI
10.6084/m9.figshare.7802222.v1

Access Dataset

https://doi.org/10.6084%2Fm9.figshare.7802222.v1

1 Article

The neoepitope landscape of breast cancer: Implications for immunotherapy
Narang, P., Chen, M., Sharma, A. A., Anderson, K. & Wilson, M. A., Mar 4 2019, In: BMC Cancer. 19, 1, 200.
Research output: Contribution to journal › Article › peer-review

Open Access
74 Scopus citations

Additional file 6: of The neoepitope landscape of breast cancer: implications for immunotherapy

Description

DOI

Access Dataset

Research output

The neoepitope landscape of breast cancer: Implications for immunotherapy

Cite this